Adaptor CAR platform: next generation of T Cell-Based cancer ommunotherapy
The success of conventional chimeric antigen receptor (CAR) therapy in the treatment of refractory hematologic malignancies has triggered the development of novel exciting experimental CAR technologies. Among them, adaptor CAR platforms have received much attention. They combine the flexibility and...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
21 May 2020
|
| In: |
Cancers
Year: 2020, Jahrgang: 12, Heft: 5 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers12051302 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers12051302 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/12/5/1302 
|
| Verfasserangaben: | Claudia Arndt, Frederick Fasslrinner, Liliana R. Loureiro, Stefanie Koristka, Anja Feldmann and Michael Bachmann |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1734043156 | ||
| 003 | DE-627 | ||
| 005 | 20220818213543.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200930s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cancers12051302 |2 doi | |
| 035 | |a (DE-627)1734043156 | ||
| 035 | |a (DE-599)KXP1734043156 | ||
| 035 | |a (OCoLC)1341368076 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Arndt, Claudia |d 1986- |e VerfasserIn |0 (DE-588)1076381049 |0 (DE-627)834819384 |0 (DE-576)445270861 |4 aut | |
| 245 | 1 | 0 | |a Adaptor CAR platform |b next generation of T Cell-Based cancer ommunotherapy |c Claudia Arndt, Frederick Fasslrinner, Liliana R. Loureiro, Stefanie Koristka, Anja Feldmann and Michael Bachmann |
| 264 | 1 | |c 21 May 2020 | |
| 300 | |a 20 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 30.09.2020 | ||
| 520 | |a The success of conventional chimeric antigen receptor (CAR) therapy in the treatment of refractory hematologic malignancies has triggered the development of novel exciting experimental CAR technologies. Among them, adaptor CAR platforms have received much attention. They combine the flexibility and controllability of recombinant antibodies with the power of CARs. Due to their modular design, adaptor CAR systems propose answers to the central problems of conventional CAR therapy, such as safety and antigen escape. This review provides an overview on the different adaptor CAR platforms available, discusses the possibilities and challenges of adaptor CAR therapy, and summarizes the first clinical experiences. | ||
| 650 | 4 | |a adaptor molecule | |
| 650 | 4 | |a adoptive T cell therapy | |
| 650 | 4 | |a cancer immunotherapy | |
| 650 | 4 | |a chimeric antigen receptor (CAR) | |
| 700 | 1 | |a Faßlrinner, Frederick |d 1983- |e VerfasserIn |0 (DE-588)1042171831 |0 (DE-627)768266564 |0 (DE-576)393734706 |4 aut | |
| 700 | 1 | |a Loureiro, Liliana R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Koristka, Stefanie |d 1987- |e VerfasserIn |0 (DE-588)1081324406 |0 (DE-627)845978837 |0 (DE-576)454123566 |4 aut | |
| 700 | 1 | |a Feldmann, Anja |d 1981- |e VerfasserIn |0 (DE-588)142966835 |0 (DE-627)641411847 |0 (DE-576)332682838 |4 aut | |
| 700 | 1 | |a Bachmann, Michael |d 1956- |e VerfasserIn |0 (DE-588)1047869977 |0 (DE-627)779362098 |0 (DE-576)401692981 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancers |d Basel : MDPI, 2009 |g 12(2020,5) Artikel-Nummer 1302, 20 Seiten |h Online-Ressource |w (DE-627)614095670 |w (DE-600)2527080-1 |w (DE-576)313958548 |x 2072-6694 |7 nnas |a Adaptor CAR platform next generation of T Cell-Based cancer ommunotherapy |
| 773 | 1 | 8 | |g volume:12 |g year:2020 |g number:5 |g extent:20 |a Adaptor CAR platform next generation of T Cell-Based cancer ommunotherapy |
| 856 | 4 | 0 | |u https://doi.org/10.3390/cancers12051302 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2072-6694/12/5/1302 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200930 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 1047869977 |a Bachmann, Michael |m 1047869977:Bachmann, Michael |p 6 |y j | ||
| 999 | |a KXP-PPN1734043156 |e 3764211075 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Claudia","family":"Arndt","role":"aut","display":"Arndt, Claudia","roleDisplay":"VerfasserIn"},{"given":"Frederick","family":"Faßlrinner","role":"aut","display":"Faßlrinner, Frederick","roleDisplay":"VerfasserIn"},{"given":"Liliana R.","family":"Loureiro","role":"aut","roleDisplay":"VerfasserIn","display":"Loureiro, Liliana R."},{"family":"Koristka","given":"Stefanie","roleDisplay":"VerfasserIn","display":"Koristka, Stefanie","role":"aut"},{"display":"Feldmann, Anja","roleDisplay":"VerfasserIn","role":"aut","family":"Feldmann","given":"Anja"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Bachmann, Michael","given":"Michael","family":"Bachmann"}],"title":[{"title":"Adaptor CAR platform","subtitle":"next generation of T Cell-Based cancer ommunotherapy","title_sort":"Adaptor CAR platform"}],"note":["Gesehen am 30.09.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1734043156","name":{"displayForm":["Claudia Arndt, Frederick Fasslrinner, Liliana R. Loureiro, Stefanie Koristka, Anja Feldmann and Michael Bachmann"]},"origin":[{"dateIssuedDisp":"21 May 2020","dateIssuedKey":"2020"}],"id":{"doi":["10.3390/cancers12051302"],"eki":["1734043156"]},"physDesc":[{"extent":"20 S."}],"relHost":[{"pubHistory":["1.2009 -"],"part":{"year":"2020","issue":"5","volume":"12","text":"12(2020,5) Artikel-Nummer 1302, 20 Seiten","extent":"20"},"disp":"Adaptor CAR platform next generation of T Cell-Based cancer ommunotherapyCancers","note":["Gesehen am 27.05.2020"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"614095670","language":["eng"],"title":[{"title_sort":"Cancers","title":"Cancers"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"2009","publisher":"MDPI","dateIssuedDisp":"2009-","publisherPlace":"Basel"}],"id":{"issn":["2072-6694"],"eki":["614095670"],"zdb":["2527080-1"]},"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]}}]} | ||
| SRT | |a ARNDTCLAUDADAPTORCAR2120 | ||